Skip to main content
Home > Conferences > BioEquity Europe > Dates, Location & Schedules > Presenting Companies Schedule
BioCentury Conference Center

Bio€quity Europe 2014 Conference Agenda

Tuesday, May 20
20:00 - 22:30

Welcome Networking Reception at Hilton Amsterdam Hotel
You may pick-up your name badge at the welcome reception. Registration will be open from 20:00 to 21:30.

Wednesday, May 21
07:45 - 09:30 Registration opens and Breakfast (Foyer)
09:00 - 09:30 Welcome and Official Greeting from the Organizers and Regional Hosts (Ballroom A & B)
09:30 - 10:30

The 7th Annual BioCentury/Ernst & Young Face-Off
(Ballroom A & B)

Bio€quity Europe's Face Off returns for a 7th year with analysis and commentary from BioCentury's 12th annual survey of European biotech financing needs and Ernst & Young's 28th Annual Beyond Borders Global Biotechnology Report.

Susan Schaeffer, Editor, BioCentury
Jürg Zürcher, Partner, EMEIA Biotechnology Leader, Ernst & Young
 
Respondents:
Arthur Franken, Partner, Gilde Healthcare
Tim Haines, Partner, Abingworth
Berndt Modig, CFO, Prosensa
10:30 - 11:00 Break
11:00 - 12:00

Premier League Challenges Plenary 1
(Ballroom A)

This opening session will debate whether the U.S. is the Premier League for raising money and what it takes to compete with U.S. companies for U.S. capital. Panelists include:

Jörn Aldag, CEO, uniQure N.V.
Dr. Joseph Anderson, Partner, Abingworth
Roel Bulthuis, Managing Director, MS Ventures
Francesco de Rubertis, Managing Partner, Index Ventures
Dr. Daniel Mahony, Portfolio Manager, Polar Capital
Antoine Papiernik, Managing Partner, Sofinnova Partners
Elise Wang, Principal, Deerfield Management

Premier League Challenges Plenary 2
(Ballroom B)

This parallel opening session asks where do European biotech drugs, diagnostics and tools stand on the league tables for differentiation and reimbursability on a global playing field? Panelists include:

Dr. Laurent Bochereau, Head of Unit, R&D Health Strategy, European Commission
Dr. Jeanne Bolger, VP of Venture Investments, Johnson & Johnson Development Corp.
Dr. Werner Lanthaler, CEO, Evotec AG
Elias Papatheodorou, CBO, Covagen AG
Dr. Rafaèle Tordjman, Managing Partner, Sofinnova Partners
Dr. Klaus Wilgenbus, SVP Business Development & Licensing/Strategy, Boehringer Ingelheim GmbH

Regional Host Showcase and Workshop
(Ballroom C)

Regional Keynote by Elizabeth Goodwin, Director of Investor Relations at Galapagos N.V. on 'Requirements for a successful Dutch biotech company', followed by Elevator Pitches from 10 young Dutch biotech companies.

Moderated by the Regional Host Group

DualTPharma
Genalice B.V.
Glycostem Therapeutics
Hearing Health Science Inc.
Incedo
Madam Therapeutics B.V.
Nutrileads B.V.
NovioSense B.V.
OrgaNext Research B.V.
SurgVision Inc.

12:00 - 14:00 Networking Luncheon (Room Diamond)
12:40 - 13:35

EMA Fireside Chat
(Ballroom C)

The European Medicines Agency calls SMEs a "motor of innovation" in the EU. BioCentury's Chairman & Editor-in-Chief Dr. Karen Bernstein interviews Dr. Jordi Llinares-Garcia — EMA's Head of Product Development Scientific Support Department and former Head of Orphan Drugs — on how the agency acts as an "enabler" for smaller players, including academia, in the pharmaceutical innovation ecosystem.

 

Presentation Rooms

Ballroom A Ballroom B Ballroom C Room Nassau
14:00 - 14:20 uniQure N.V. (NASDAQ:QURE) Prosensa Holding B.V. (NASDAQ:RNA)

Next Wave Company Presentations
(14:00-16:00)

Calypso Biotech S.A.
Canbex Therapeutics Ltd.
SynAffix B.V.
Asceneuron S.A.
Prexton Therapeutics S.A.
Hermo Pharma Ltd.
nLife Therapeutics S.L.
Saniona AB
Treeway B.V.
Chord Therapeutics S.a.r.l.
ObsEva S.A.
Forendo Pharma Oy

CEO Boot camp #5
How do the Founders Stay in the C-suite?
(14:15 - 15:15)

Optimizing Management:
For a fifth year, Bio€quity Europe provides core lessons for biotech CEOs. This year's focus is on how top management skill sets change as a company matures. Panelists include:

Matthieu Coutet, Managing Partner, Inserm Transfert Initiative
Dr. Hakan Goker, Partner, MS Ventures

Dr. Deborah Harland, Partner, SROne

Dr. Allan Marchington, Partner, Apposite Capital
Carole Nuechterlein, Head, Roche Venture Fund

14:20 - 14:40

Opsona Therapeutics Ltd. Piqur Therapeutics AG
14:40 - 15:00 CureVac GmbH Vaximm AG
15:00 - 15:20 4SC AG (Xetra:VSC) Immunocore Ltd.
15:20 - 15:40 ISA Pharmaceuticals B.V. Addex Therapeutics Ltd. (SIX:ADXN)

Plenary 1 Seminar
International Fundraising: Crossing the Pond for a U.S. IPO

(15:30 - 16:30)

Advice from experienced dealmakers and investors. Panelists include:

Neil Mackison, Managing Director, Head of European Healthcare, Piper Jaffray
Dr. Jörg Neermann, Partner, LSP
Ian Oliver, Senior Manager, Health Sciences, Biotech, Ernst & Young
Hans Schikan, CEO, Prosensa
Graziano Seghezzi, Partner, Sofinnova Partners
Al Sokol, Partner, Edwards Wildman
15:40 - 16:00 Cevec Pharmaceuticals GmbH MediGene AG (Xetra:MDG)
16:00 - 16:20 Genmab A/S (CSE:GEN; OTCBB:GMXAY) AC Immune S.A. Curetis AG
16:20 - 16:40 Evotec AG (Xetra:EVT) Noxxon Pharma AG Probiodrug AG
16:40 - 17:00 Oxyrane U.K. Ltd. Benitec Biopharma Ltd. (ASX:BLT) Transgene S.A. (Euronext:TNG)

Next Wave Company Presentations
(16:50-18:20)

Aelis Farma S.A.S.
Enyo Pharma S.A.S.
Eyevensys S.A.S.
GenSight Biologics Inc.
AAVLife
ArisGen S.A.
Lanthio Pharma B.V.
MiNA Therapeutics Ltd.
Numab AG

17:00 - 17:20 Hookipa Biotech AG to-BBB technologies B.V. EpiTherapeutics ApS
17:20 - 17:40 TiGenix N.V. (Euronext:TIG) Covagen AG Anergis S.A.
17:40 - 18:00 Oryzon Genomics S.A. Midatech Ltd. Affimed Therapeutics AG
18:00 - 18:20 Genkyotex S.A.

Pharma Diagnostics N.V.

Erytech Pharma S.A. (Euronext:ERYP)
18:30 - 19:00 Bus Transfer to Evening Reception and Dinner
19:00 - 23:00 Networking Reception and Dinner
Pompstation Amsterdam
Zeeburgerdijk 52 | Amsterdam
Thursday, May 22
07:45 - 09:30 Registration opens and Breakfast (Foyer)
 

Presentation Rooms

Ballroom A Ballroom B Ballroom C Room Nassau
09:00 - 09:20 Adenium Biotech ApS Santhera Pharmaceuticals Holding AG (SIX:SANN)

Next Wave Company Presentations
(09:00-12:40)

Cormorant Pharmaceuticals AB
Cristal Therapeutics
ProFactor Pharma Ltd.
OctreoPharm Sciences GmbH
LinXis B.V.
Oncos Therapeutics Ltd.
NBE-Therapeutics AG
Genable Technologies Ltd.
MedLumics S.A.
reViral Ltd.
SeaLife Pharma GmbH
Instep Orphan Therapeutics
Corline Systems AB
Acousia Therapeutics GmbH
Audion Therapeutics B.V.
LinguaFlex Inc.
Mint Solutions
Sapiens Steering Brain Stimulation B.V.
TheraSolve N.V.
PathoQuest S.A.S.
Hemics B.V.

 

 

09:20 - 09:40 Active Biotech AB (SSE:ACTI) arGEN-X B.V.

CEO Q&A
Q&A Session: Fireside Chats: War Stories from Those Who Adapted

(09:30 - 10:25)

Bio€quity Europe continues its tradition of intimate Q&A sessions, this year offering lessons from CEOs who have managed their way through challenging times. Panelists include:

Stéphane Boissel, EVP and CFO, Transgene
Eduardo Bravo, CEO, TiGenix
Timothy Dyer, CEO, Addex Therapeutics

Dr. Matthew Geller, Founder and Managing Director, Geller Biopharm

Dr. Martin Welschof, CEO, Opsona Therapeutics
09:40 - 10:00 Oncopeptides AB Vectura Group plc (LSE:VEC)
10:00 - 10:20 TauRx Pharmaceuticals Ltd. Theravectys S.A.
10:20 - 10:40 Nanobiotix S.A. (Euronext: NANO) Prosonix Ltd.

Ernst & Young - Breakout Session
(10:30 - 11:30)

Ernst & Young's team presents key data sets from its upcoming Beyond Borders report with emphasis on European figures and trends. Panelists include:

Dr. Siegfried Bialojan, Head, Life Science Center GmbH, Ernst & Young
Jürg Zürcher, Partner, EMEIA Biotechnology Leader, Ernst & Young
10:40 - 11:00 Polynoma LLC Sygnis Pharma AG (Xetra:LIO1)
11:00 - 11:20 Promethera Biosciences S.A. Biotie Therapies Corp. (HSE:BTH1V)
11:20 - 11:40 Galecto Biotech AB BIRD-C GmbH
11:40 - 12:00 Atlas Genetics Ltd. Neovacs S.A. (Euronext:ALNEV) Buyside Q&A
(11:45 - 12:45)

Intimate sessions with investors from the US and EU on what they look for in new issues, syndicate building and financing for growth. Panelists include:

Jonas Brambeck, Investment Manager, Industrifonden
Kai Brüning, Portfolio Manager, Apo Asset Management
Saad Gilani, Head, Healthcare Investments, Yorkville Advisors
Dr. Joep Muijrers, Partner, LSP
12:00 - 12:20 Newron Pharmaceuticals S.p.A. (SIX:NWRN) F-star GmbH
12:20 - 12:40   TikoMed AB
12:45 - 14:00 Networking Luncheon (Room Diamond)
14:00 - 14:20 ActoGeniX N.V. Verona Pharma plc (LSE:VRP) Navidea Biopharmaceuticals Inc. (NYSE-M:NAVB)  
14:20 - 14:40 Cardiorentis AG AM-Pharma B.V. Agenus Inc. (NASDAQ:AGEN)
14:40 - 15:00 Biomay AG AIMM Therapeutics B.V. Versartis Inc. (NASDAQ:VSAR)
15:00 - 15:20 Umecrine Mood AB Synthetic Biologics Inc. (NYSE-M:SYN) Resverlogix Corp. (TSX:RVX)
15:20 - 15:40 Kiadis Pharma B.V. Enterome Bioscience NephroGenex Inc. (NASDAQ:NRX)
15:45 - 16:30

Networking Closing Reception (Foyer)
Hosted by
LISAvienna
Regional Host of Bio€quity Europe 2015